
A common dietary supplement may help overcome mutations in the Pten gene. Should patients take it? GINA KOLATA https://nyti.ms/2VwHNL9 http://bit.ly/2LRroS8 The New York Times Health Breast Cancer, Genetics and Heredity, Drugs (Pharmaceuticals) May 17, 2019 at 12:00AM
Comments
Post a Comment